Arrhythmia Cohort Study

NCT07123896 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Anzhen Hospital

Phase

Observational

Started

2025-08-24

Last updated

2025-08-14

Condition(s) studied

Arrhythmia

Investigational drug(s) / intervention(s)

Normal treatment with catheter ablation or medicineDrug Treatment

Normal treatment with catheter ablation or medicine: Routine clinical care with catheter ablation and/or medicine; real-world clinical cases

Drug Treatment: Routine clinical care with medicine; real-world clinical cases

Study summary

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

Eligibility

Sex

ALL

Min age

18 Years

Max age

90 Years

Healthy volunteers

Inclusion Criteria: * Patients hospitalized for any type of arrhythmia Exclusion Criteria: * Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.

Primary outcome measure(s)

Arrhythmia recurrence — 1 year
Recurrence of the arrhythmia after treatment
All-cause death — 1 year
Death due to any reason

Trial sites (1)

Facility	City	Region	Status
Deyong Long	Beijing	China

More Beijing Anzhen Hospital trials in China

China Extracorporeal Life Support Registry Recruiting

A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment Recruiting

Intracardiac Echocardiography-Guided Cavotricuspid Isthmus Ablation With a Circular-Shaped Pulsed Field Ablation Catheter Recruiting

The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD) Starting soon

Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment Starting soon

Other trials for the same condition

Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement Active, not recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting

Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting Recruiting

Deep Learning for Intelligent Identification of Arrhythmias Starting soon

The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion. Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07123896 on ClinicalTrials.gov ↗ ← All trials in China